- Have any questions? Contact us!
- info@dr-rath-foundation.org
September 25, 2026
Cefepime is a fourth-generation antibiotic widely used to treat serious bacterial infections and febrile neutropenia – a fever in patients with abnormally low white blood cell counts. However, scientists are concerned that this widely effective antibiotic may increase the risk of death.
September 18, 2026
A Novartis drug designed to lower levels of Lp(a), a known cardiovascular risk factor, failed to reduce patients’ risk of a heart attack, stroke, or other major cardiovascular events in the first late-stage test for a drug meant to tackle the mysterious molecule.
September 18, 2026
Two common GLP-1 weight-loss drugs have been linked to a brain condition that can cause permanent brain damage and become deadly.
September 18, 2026
About eight-in-ten U.S. adults say they are currently taking at least one supplement for their health, according to a new Pew Research Center survey.
September 18, 2026
A combination of magnesium and vitamin D may modestly reduce hypertension, according to a review evaluating emerging evidence on the synergy of these nutrients.
September 18, 2026
A study quantifying the associations of parental vitamin B12 and red blood cell (RBC) folate with birth defects found that higher parental vitamin B12 before conception and higher maternal RBC folate concentrations after conception were associated with lower birth defect risk.
September 11, 2026
Slovakia says it will challenge the European Union’s new law deregulating most gene-edited plants, Prime Minister Robert Fico has announced, taking concerns about precaution, transparency and consumer choice to the Court of Justice of the European Union, the EU’s highest court.
Nearly a Decade of Research Strengthens the Case for Vitamin D in Pregnancy